Skip to main content
. Author manuscript; available in PMC: 2015 May 15.
Published in final edited form as: AIDS. 2014 May 15;28(8):1125–1134. doi: 10.1097/QAD.0000000000000203

Figure 1. Virologic failure was faster and more common in patients with lower genotypic susceptibility scores during low-level viraemia.

Figure 1

Kaplan-Meier curves for the proportion of patients remaining on the same therapy with viral loads <1000 copies/mL following their first low-level viraemia (LLV) episode. Patients are divided into 4 groups according to their GSS, and followed for up to five years while remaining on constant therapy. Patients with GSS ≥3 had the best outcomes following LLV, while patients with GSS <1 had the worst outcomes. The survival curves were all significantly different by the log-rank test (p<0.001). The numbers of patients remaining at risk at each six month interval are shown below the figure. Ticks represent censoring of patients suppressing on the same therapy, changing therapy, lost to follow-up, or at their last available time point.